Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308624596> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4308624596 endingPage "5" @default.
- W4308624596 startingPage "1" @default.
- W4308624596 abstract "Purpose. To report a rare case of left-sided metastatic optic nerve infiltration and right-sided choroidal mass with exudative retinal detachment caused by EGFR exon 19 deletion positive non-small-cell lung adenocarcinoma that responded to targeted therapy with osimertinib (EGFR-TKI). Our patient demonstrated an excellent response with reduced size of the metastatic choroidal mass of the right orbit and improved visual acuity, in addition to systemic disease control. Case. A 66-year-old male patient with a history of diabetes mellitus, hypertension, and tobacco use presented with sudden vision loss in the left eye secondary to optic nerve infiltration and subacute vision loss in the right eye secondary to exudative retinal detachment from a choroidal metastasis. He was found to have a right lung mass, multiple metastatic pulmonary nodules, and liver and bone metastases. Biopsy from a mediastinal lymph node confirmed the diagnosis of metastatic lung adenocarcinoma. He was found to have exon 19 deletion on next-generation sequencing. We treated him with local radiation therapy to the left eye and systemic osimertinib (EGFR-TKI). Conclusion. To our knowledge, our case is the first report of a patient who initially presented with acute vision loss and was found to have metastatic retrobulbar optic nerve infiltration in one eye and metastatic choroidal lesion with exudative retinal detachment in the fellow eye secondary to lung adenocarcinoma. Due to the rarity of this condition, literature regarding effective treatment is scarce. Our patient demonstrated significant improvement in visual acuity and resolution of exudative retinal detachment in the right eye following osimertinib treatment and radiation therapy to the left eye. Further investigation into the role of tyrosine kinase inhibitors and radiation therapy in treating intraocular metastasis involving the optic nerve is needed." @default.
- W4308624596 created "2022-11-13" @default.
- W4308624596 creator A5017233177 @default.
- W4308624596 creator A5053283764 @default.
- W4308624596 creator A5061697481 @default.
- W4308624596 creator A5063350342 @default.
- W4308624596 creator A5081934452 @default.
- W4308624596 creator A5084509697 @default.
- W4308624596 date "2022-11-09" @default.
- W4308624596 modified "2023-09-27" @default.
- W4308624596 title "Sudden Vision Loss Secondary to Optic Nerve Infiltration as a Presenting Symptom of Metastatic Lung Adenocarcinoma" @default.
- W4308624596 cites W1988337774 @default.
- W4308624596 cites W2027800775 @default.
- W4308624596 cites W2033070375 @default.
- W4308624596 cites W2090662784 @default.
- W4308624596 cites W2126203715 @default.
- W4308624596 cites W2770828094 @default.
- W4308624596 cites W2989957241 @default.
- W4308624596 cites W4214691615 @default.
- W4308624596 doi "https://doi.org/10.1155/2022/3614225" @default.
- W4308624596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36404806" @default.
- W4308624596 hasPublicationYear "2022" @default.
- W4308624596 type Work @default.
- W4308624596 citedByCount "0" @default.
- W4308624596 crossrefType "journal-article" @default.
- W4308624596 hasAuthorship W4308624596A5017233177 @default.
- W4308624596 hasAuthorship W4308624596A5053283764 @default.
- W4308624596 hasAuthorship W4308624596A5061697481 @default.
- W4308624596 hasAuthorship W4308624596A5063350342 @default.
- W4308624596 hasAuthorship W4308624596A5081934452 @default.
- W4308624596 hasAuthorship W4308624596A5084509697 @default.
- W4308624596 hasBestOaLocation W43086245961 @default.
- W4308624596 hasConcept C118487528 @default.
- W4308624596 hasConcept C121608353 @default.
- W4308624596 hasConcept C126322002 @default.
- W4308624596 hasConcept C142724271 @default.
- W4308624596 hasConcept C2777714996 @default.
- W4308624596 hasConcept C2778257484 @default.
- W4308624596 hasConcept C2779013556 @default.
- W4308624596 hasConcept C2780837183 @default.
- W4308624596 hasConcept C2781182431 @default.
- W4308624596 hasConcept C71924100 @default.
- W4308624596 hasConceptScore W4308624596C118487528 @default.
- W4308624596 hasConceptScore W4308624596C121608353 @default.
- W4308624596 hasConceptScore W4308624596C126322002 @default.
- W4308624596 hasConceptScore W4308624596C142724271 @default.
- W4308624596 hasConceptScore W4308624596C2777714996 @default.
- W4308624596 hasConceptScore W4308624596C2778257484 @default.
- W4308624596 hasConceptScore W4308624596C2779013556 @default.
- W4308624596 hasConceptScore W4308624596C2780837183 @default.
- W4308624596 hasConceptScore W4308624596C2781182431 @default.
- W4308624596 hasConceptScore W4308624596C71924100 @default.
- W4308624596 hasFunder F4320310585 @default.
- W4308624596 hasLocation W43086245961 @default.
- W4308624596 hasLocation W43086245962 @default.
- W4308624596 hasLocation W43086245963 @default.
- W4308624596 hasOpenAccess W4308624596 @default.
- W4308624596 hasPrimaryLocation W43086245961 @default.
- W4308624596 hasRelatedWork W1969927172 @default.
- W4308624596 hasRelatedWork W1994125017 @default.
- W4308624596 hasRelatedWork W2139322190 @default.
- W4308624596 hasRelatedWork W2313577740 @default.
- W4308624596 hasRelatedWork W2349999257 @default.
- W4308624596 hasRelatedWork W2354275354 @default.
- W4308624596 hasRelatedWork W2368688319 @default.
- W4308624596 hasRelatedWork W2388915439 @default.
- W4308624596 hasRelatedWork W3005652238 @default.
- W4308624596 hasRelatedWork W3089996564 @default.
- W4308624596 hasVolume "2022" @default.
- W4308624596 isParatext "false" @default.
- W4308624596 isRetracted "false" @default.
- W4308624596 workType "article" @default.